NOTRELOAD AI
Invest ↗
myNOTRELOAD (BETA)
XY Feed
24-HOUR Pass →

Sign in Subscribe

Qiagen Sale Speculation: KKR, EQT and the $50 Question

Qiagen reviews options with Goldman and Moelis.

Credit: Qiagen

Already have an account? Sign in.

Featured/ 09/17/2026 · 7:29 AM

/ Don’t stop at just one post.

Related↓

Featured/ 07/09/2026 · 11:53 AM

Qiagen Draws Early Takeover Interest from EQT, Advent, and KKR

No formal bids yet as the ~$9B molecular diagnostics leader faces sector consolidation.

/ Subscriber only

Featured/ 01/20/2026 · 11:52 AM

Qiagen Considers Sale as Takeover Interest Returns

Qiagen is reviewing strategic options, including a possible sale, as takeover interest resurfaces in the fast-growing life sciences and diagnostics sector.

/ Subscriber only

11/04/2025 · 4:00 PM

QIAGEN Acquires Parse Biosciences to Boost Single-Cell Research Capabilities

QIAGEN announces its $225 million acquisition of Parse Biosciences, expanding into scalable single-cell technologies to power AI-driven biological research and drug discovery.

/ Subscriber only

/ Read more

Feed↓

Featured/ 09/19/2026 · 10:02 AM

Anthropic Pushes Stock-Market Debut to November

Anthropic may go public in November at about $2 trillion after delaying an October window to show Q3 results following OpenAI’s Astra launch.

/ Subscriber only

09/18/2026 · 3:02 PM

Major Wendy’s Franchisee Files for Chapter 11 Bankruptcy

Meritage, operator of 314 Wendy’s restaurants, filed for bankruptcy protection and is seeking financing to keep stores open.

/ Subscriber only

Featured/ 09/18/2026 · 11:27 AM

Barclays Flags Cost Cuts, Cable Decline, and Integration Risk in Paramount-Warner Merger

The $110B Warner deal offers growth but faces execution risk, cable decline, and delays.

/ Subscriber only

UP↑
Terms/Privacy
Sign up
Sign in
Discord
X
Bluesky
Telegram
Reach out →
Invest ↗
NOTRELOAD AI

DON'T FALL BEHIND. ©2025

Email address Subscribe